Related Experiment Video

Updated: Aug 19, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

Gene therapy for the treatment of mitochondrial DNA disorders

Robert W Taylor1

  • 1University of Newcastle upon Tyne, Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, Newcastle upon Tyne, NE2 4HH, UK. r.w.taylor@ncl.ac.uk

Expert Opinion on Biological Therapy
|March 11, 2005
PubMed

Insights

Mitochondrial respiratory chain disorders are common inherited diseases with limited treatments. This review explores novel gene therapy strategies and therapeutic exercise for these complex genetic conditions.

Area of Science:

  • Genetics
  • Molecular Biology
  • Human Disease

Background:

  • Mitochondrial respiratory chain disorders are common inherited diseases.
  • Current treatments are limited due to genetic complexities and poor response to conventional therapies.
  • Novel therapeutic strategies are urgently needed.

Purpose of the Study:

  • To review the current understanding of mitochondrial genetics and associated disorders.
  • To introduce and evaluate emerging gene therapy strategies for mitochondrial DNA mutations.
  • To discuss the potential of therapeutic exercise as a treatment modality.

Main Methods:

  • Review of existing epidemiological and genetic studies.
  • Analysis of in vitro, cell culture, and animal models of mitochondrial disorders.
  • Examination of clinical data from therapeutic exercise interventions.

Main Results:

  • Gene therapy approaches show promise for treating mitochondrial DNA mutations.
  • Therapeutic exercise is being explored as a viable treatment in patients.
  • Challenges remain in developing effective and safe treatments.

Conclusions:

  • Innovative approaches like gene therapy are essential for treating mitochondrial disorders.
  • Further research and development are needed to translate promising strategies into clinical practice.
  • A multi-faceted approach combining genetic and lifestyle interventions may offer future therapeutic avenues.

More Related Videos

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred irrespective...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...